Australia's ReNerve hits record high on device's positive clinical trial results

Renerve

28/03/2025 03:06

** ReNerve RNV.AX swells 98.8% to a record high of A$0.220; last up 40.9%

** Stock set for biggest ever intraday pct gain

** Medical devices maker says patients using its NervAlign® Nerve Cuff, which aids regeneration of peripheral nerves after surgery or injury, reported significantly lower post-surgery pain

** RNV set to end the quarter 11.4% lower

** About 4.5 mln shares traded in stock's busiest session ever

** RNV loses 5.7% YTD

 (Reporting by Manasi Dasa Sundeep in Bengaluru)

 ((Manasi.DasaSundeep@thomsonreuters.com;))